Latest Articles
AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment - NewsGram
AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment NewsGram
Published: Feb. 11, 2026, 3:33 a.m.
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication - thehindu.com
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication thehindu.com
Published: Feb. 10, 2026, 9:33 a.m.
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication - The Hindu
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication The Hindu
Published: Feb. 10, 2026, 9:33 a.m.
AstraZeneca gets Indian regulator's nod to market cancer drug Imfinzi - Business Standard
AstraZeneca gets Indian regulator's nod to market cancer drug Imfinzi Business Standard
Published: Feb. 10, 2026, 9:10 a.m.
AstraZeneca gets CDSCO nod to market cancer drug Imfinzi for additional indication - The Economic Times
AstraZeneca gets CDSCO nod to market cancer drug Imfinzi for additional indication The Economic Times
Published: Feb. 10, 2026, 8:44 a.m.
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug - CNBC TV18
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug CNBC TV18
Published: Feb. 10, 2026, 6:11 a.m.
AstraZeneca Pharma India Gets CDSCO Nod for Cancer Drug Imfinzi - Whalesbook
AstraZeneca Pharma India Gets CDSCO Nod for Cancer Drug Imfinzi Whalesbook
Published: Feb. 10, 2026, 5:34 a.m.
Emerging Trends and Treatment Strategies in Ovarian Cancer: A Comprehensive Review.
Ovarian cancer (OC) is the eighth leading cause of cancer deaths in women globally, mainly originating from epithelial cells. It is further divided into type-I and type-II based on histology, …
Published: Feb. 3, 2026, midnight
Complication Rates and Management in Sentinel Lymph Node Biopsy for Endometrial Cancer: A Retrospective Cohort Study - Frontiers
Complication Rates and Management in Sentinel Lymph Node Biopsy for Endometrial Cancer: A Retrospective Cohort Study Frontiers
Published: Jan. 30, 2026, 6:10 p.m.
Attenuated Cyclooxygenase-Mediated Vasodilation in Cutaneous Microvasculature with No Difference in Platelet Aggregation in Women with Endometriosis.
Endometriosis is a systemic inflammatory disease known to increase the risk of cardiovascular disease. The inducible form of cyclooxygenase (COX), COX-2, is an inflammatory enzyme upregulated in endometriosis with COX …
Published: Jan. 30, 2026, midnight
Link copied to clipboard!